WHO ICTRP trial
Acarbose Cardiovascular Evaluation Trial
ISRCTN91899513 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN91899513 |
|---|---|
| Public title | Acarbose Cardiovascular Evaluation Trial |
| Scientific title | The Acarbose Cardiovascular Evaluation (ACE) Trial: A long-term, multicentre, double-blind, randomised parallel-group trial to determine whether reducing post-prandial glycaemia can reduce cardiovascular-related morbidity and mortality in patients with established coronary heart disease or acute… |
| Primary sponsor | University of Oxford (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase IV |
| Countries | China;United Kingdom;England |
| Conditions | Coronary heart disease, acute coronary syndrome, impaired glucose tolerance, type 2 diabetes mellitus Circulatory System Chronic ischaemic heart disease |
| Interventions | Current interventions as of 01/08/2017: Acarbose (oral) vs placebo The participants in the intervention group were given one tablet (50 mg) of acarbose per day to be taken with a meal during the first week (7 days). During the second week… |
| Registration date | Dec 11, 2008 |
| Target size | 6500 |
| Secondary IDs | Nil known;NCT00829660;11232 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: